Naumovich Vladislav, Kandagalla Shivananda, Grishina Maria
Laboratory of Computational Modeling of Drugs, Higher Medical & Biological School, South Ural State University, Chelyabinsk, 454008, Russia.
Thinkmolecular Technologies Private Limited, Bangalore, 560102, India.
Future Med Chem. 2024 Dec;16(24):2599-2607. doi: 10.1080/17568919.2024.2419350. Epub 2024 Nov 12.
To develop a model for predicting the biological activity of compounds targeting the HIV-1 protease and to establish factors influencing enzyme inhibition. Machine learning models were built based on a combination of Richard Bader's theory of Atoms in Molecules and topological analysis of electron density using experimental x-ray 'protein-ligand' complexes and inhibition constants data. Among all the models tested, logistic regression achieved the highest accuracy of 0.76 on the test set. The model's ability to differentiate between less active and highly active classes was relatively good, as indicated by an AUC-ROC score of 0.77. The analysis identified several critical factors affecting the biological activity of HIV-1 protease inhibitors, including the electron density contribution of hydrogen atoms, bond-critical points and particular amino acid residues. These findings provide new insights into how these molecular factors influence HIV-1 protease inhibition, emphasizing the importance of hydrogen bonding, glycine's flexibility and hydrophobic interactions in ligand binding.
开发一种用于预测靶向HIV-1蛋白酶的化合物生物活性的模型,并确定影响酶抑制的因素。基于理查德·巴德的分子中原子理论与使用实验X射线“蛋白质-配体”复合物和抑制常数数据的电子密度拓扑分析相结合,构建了机器学习模型。在所有测试的模型中,逻辑回归在测试集上达到了最高准确率0.76。该模型区分低活性和高活性类别能力相对较好,AUC-ROC评分为0.77表明了这一点。分析确定了几个影响HIV-1蛋白酶抑制剂生物活性的关键因素,包括氢原子的电子密度贡献、键临界点和特定氨基酸残基。这些发现为这些分子因素如何影响HIV-1蛋白酶抑制提供了新的见解,强调了氢键、甘氨酸的灵活性和疏水相互作用在配体结合中的重要性。